Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
Interest Income Expense
Alkermes Plc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Alkermes Plc
NASDAQ:ALKS
|
Interest Income Expense
$11.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Interest Income Expense
$13m
|
CAGR 3-Years
101%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Interest Income Expense
$31.5m
|
CAGR 3-Years
440%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Interest Income Expense?
Interest Income Expense
11.6m
USD
Based on the financial report for Mar 31, 2024, Alkermes Plc's Interest Income Expense amounts to 11.6m USD.